Why physicians should worry about proposed federal changes to medication pricing Blood clots may be linked to AstraZeneca vaccine but still very rare: Health Canada Unusual treatment shows promise for kids with brain tumors Virtual solutions Some provincial governments haven’t committed to continuing virtual care fee codes after the pandemic. Health Canada investigating blood clot reports after U.S. pauses J&J vaccine Book review: Posner puts Pharma under the microscope A book neither pharma-sympathetic, nor anti-pharma, it still offers up big insights on the pharmaceutical industry. Editorial: The stumble toward virtual care Virtual care is here to stay but now we need to iron out the kinks. The digital touch The doctor-patient relationship is stronger when there’s a virtual component. Adverse effect rates with Pfizer-BioNTech and Moderna COVID-19 vaccines Active surveillance system collects near–real-time data from mRNA COVID-19 vaccine recipients in the United States. Costing virtual care Picking out what virtual care fee codes will do to physician services budgets is hard with COVID changing all aspects of utilization. First Previous 682 683 684 685 686 Next Last
